全文获取类型
收费全文 | 19957篇 |
免费 | 1386篇 |
国内免费 | 616篇 |
专业分类
耳鼻咽喉 | 46篇 |
儿科学 | 462篇 |
妇产科学 | 358篇 |
基础医学 | 2542篇 |
口腔科学 | 325篇 |
临床医学 | 2110篇 |
内科学 | 2729篇 |
皮肤病学 | 286篇 |
神经病学 | 749篇 |
特种医学 | 370篇 |
外国民族医学 | 3篇 |
外科学 | 949篇 |
综合类 | 3253篇 |
现状与发展 | 1篇 |
预防医学 | 1710篇 |
眼科学 | 212篇 |
药学 | 3476篇 |
18篇 | |
中国医学 | 1469篇 |
肿瘤学 | 891篇 |
出版年
2023年 | 175篇 |
2022年 | 385篇 |
2021年 | 608篇 |
2020年 | 571篇 |
2019年 | 539篇 |
2018年 | 507篇 |
2017年 | 612篇 |
2016年 | 638篇 |
2015年 | 627篇 |
2014年 | 1094篇 |
2013年 | 1383篇 |
2012年 | 1001篇 |
2011年 | 1198篇 |
2010年 | 938篇 |
2009年 | 780篇 |
2008年 | 800篇 |
2007年 | 846篇 |
2006年 | 820篇 |
2005年 | 708篇 |
2004年 | 673篇 |
2003年 | 596篇 |
2002年 | 514篇 |
2001年 | 411篇 |
2000年 | 351篇 |
1999年 | 271篇 |
1998年 | 291篇 |
1997年 | 275篇 |
1996年 | 259篇 |
1995年 | 247篇 |
1994年 | 256篇 |
1993年 | 258篇 |
1992年 | 228篇 |
1991年 | 198篇 |
1990年 | 202篇 |
1989年 | 195篇 |
1988年 | 173篇 |
1987年 | 173篇 |
1986年 | 123篇 |
1985年 | 363篇 |
1984年 | 289篇 |
1983年 | 252篇 |
1982年 | 224篇 |
1981年 | 194篇 |
1980年 | 154篇 |
1979年 | 107篇 |
1978年 | 99篇 |
1977年 | 77篇 |
1976年 | 61篇 |
1975年 | 46篇 |
1973年 | 32篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
81.
Cyclic hormonal replacement therapy after the menopause: Transdermal versus oral treatment 总被引:2,自引:0,他引:2
M. Cortellaro T. Nencioni C. Boschetti S. Ortolani F. Buzzi B. Francucci M. P. Caraceni P. Abelli F. Polvani C. Zanussi 《European journal of clinical pharmacology》1991,41(6):555-559
Summary In an open, randomized, comparative, between-patient trial, 45 postmenopausal women were treated for 4 months with cyclical transdermal oestradiol 0.05 mg per day or oral conjugated equine oestrogens 0.625 mg per day, in both cases, plus, medroxyprogesterone acetate 10 mg per day on the last 8 days of each cycle. Similar relief from postmenopausal symptoms was obtained with both treatments. Post-treatment histological evaluation of the endometrium did not reveal neoplastic or hyperplastic change in any patient.Early follicular-phase plasma oestradiol levels were observed only after transdermal oestradiol. There was a significant reduction in serum total cholesterol and LDL cholesterol in both treatment groups, with no difference between treatments, whereas serum triglyceride levels were decreased only by transdermal oestradiol. Plasma calcium and phosphorus fell significantly and serum intact parathyroid hormone rose significantly, with no difference between the therapies. No significant changes were observed in clotting factors.Transdermal oestradiol appears to be an effective and safe hormonal replacement therapy, and this route of administration may be responsible for the more useful action of the drug on serum lipids and plasma oestradiol levels. 相似文献
82.
血钙水平与肾癌肿瘤大小、分期的相关性分析 总被引:2,自引:0,他引:2
目的分析肾细胞癌患者血钙水平和肿瘤大小与分期的相关性,从而进一步发现与病情相关的规律和了解病情。方法按照血钙水平将肿瘤大小/分期相应地分3组,即降低、正常和升高各3组。利用SPSS10.0软件,对3组不同的肿瘤大小/分期病例进行差异性分析和相关性研究。结果3组不同的肿瘤大小差异性分析(Kruskal-wallisH)显示,X^2=4.768,df=2,P=0.092;Spearman相关分析显示相关系数为.0.166,P=0.029。3组不同的肿瘤分期差异性分析(Kruskal-Wallis H)显示,X^2=4、277,df=2,P=0.118;Spearman相关系数为.0.157,P=-0.039。结论3组不同的肿瘤大小之间差异性无统计学意义,血钙水平与肿瘤大小间存在负相关;3组不同的肿瘤分期之间差异性无统计学意义,血钙水平与肿瘤分期间存在负相关。 相似文献
83.
Yoshinori Uji Arthur Karmen Hiroaki Okabe Keishi Hata Masakazu Miura Kazuyuki Ozaki Mitsuo Minamizaki Tetsushi Shibata Seiichi Inayama 《Journal of clinical laboratory analysis》1994,8(5):267-272
An automated measurement of total and free hydroxyproline in serum or urine is presented that uses flow injection analysis. After exclusion of nonspecific substances, hydroxyproline was oxidized by chloramine- T and L-cysteine with Ehrlich's reagent. The linearity obtained was from 3.8μmole/ L to 1.22 mmole/L with good precision (CV <3%). Comparison of the proposed method with HPLC yielded r = 0.939 as the correlation coefficient. Reference intervals of free and total hydroxyproline are 1.4–9.7 μmole/L, 3.8–27.2 μmole/L for serum, and 10.0–72.5 μmole/L, 25.2–303.6 μmole/L for urine, respectively. Serum free and total hydroxyproline levels in renal osteodystrophy patients on maintenance hemodialysis (N = 71) were significantly higher than in controls (P<0.0001). This method is superior to the use of HPLC with regard to stability of the color reaction. The measurement of serum free and total hydroxyproline is a useful marker for therapeutic observation of renal osteodystrophy patients. © 1994 Wiley-Liss, Inc. 相似文献
84.
目的:测定妊高征患者血清睾酮水平并探讨其临床意义。方法:采用放射免疫分析法测定妊高征患者30例、正常孕妇20例血清及其新生儿脐血睾酮水平。结果:妊高征患者血清睾酮水平(0.153±0.078nmol/L)明显高于正常孕妇组(0.023±0.015nmol/L),有显著性差异(P<0.001)。妊高征组脐血睾酮水平(0.052±0.041nmol/L)低于正常孕妇组(0.119±0.059nmol/L),有显著性差异(P<0.05),两组睾酮水平与新生儿性别无关(P>0.05)。结论:孕妇血清睾酮在妊高征的病理生理中起调节或加强作用。 相似文献
85.
86.
实验比较了高脂兔血清(HRS)和正常兔血清(NRS)对培养的人脐静脉内皮细胞(EC)脂质过氧化物(LPO)的形成和EC利用外源性花生四烯酸(AA)合成前列环素(PGI2)能力的影响;同时观察了抗氧化剂VitE对EC的保护作用。结果表明,HRS对EC合成PGI2的影响有一时间和浓度相关的反应过程。用HRS孵育培养呈融合状的EC,在48h前刺激PGI2的产生,48h达最高值,然后急骤下降;而LPO含量随着孵育时间的延长呈直线上升(r=0.987)。随着HRS浓度的增加,LPO含量逐渐升高,EC合成PGI2能力呈下降趋势。VitE可阻止HRS引起的EC中LPO含量的增加和PGI2合成能力的下降。 相似文献
87.
Day-to-day variations in serum iron, serum iron binding capacity, serum ferritin and erythrocyte protoporphyrin were determined on 2 successive days in 48 patients with anaemia. The correlation coefficients between the paired determinations were 0.86, 0.89, 0.95 and 0.95, and the day-to-day coefficients of variation (in per cent) were 33, 11, 12 and 13 for serum iron, serum iron binding capacity, erythrocyte protoporphyrin and serum ferritin, respectively. Thus, in patients with anaemia, day-to-day variations in serum iron, serum iron binding capacity, erythrocyte protoporphyrin and serum ferritin are at least as high as in healthy controls. The results indicate important limitations in the use, particularly, of serum iron in the clinical investigation of anaemia. 相似文献
88.
Kaoru Hatanaka Xiang-An Li Ling Guo Toshiyuki Sakata Judith A. Gillissen Akira Yoshioka Akira Yamamoto 《Thrombosis research》1994,74(6):643-654
We have experienced a coagulation factor VIII-deficient patient whose plasma has normal protein S (PS) activity and masses of free PS and its bound form in complex with C4b-binding protein (C4BP). Although the patient's plasma showed a normal ratio of free PS to PS-C4BP complex in the presence of 5 mM EDTA, the plasma gave an abnormally retarding major C4BP peak together with a major PS peak in the crossed immunoelectrophoresis (CIE) in the presence of 2 mM CaCl2. It was revealed that the major peak was formed by a mixture of PS-C4BP complex and free form. The addition of normal human plasma (NHP) to the patient's plasma inhibited the retardation of the major PS-C4BP complex. These suggest that the patient's plasma lacks some component(s) to inhibit Ca2+-dependent association of PS with C4BP. 相似文献
89.
Yohei Ogawa Makoto Hiura Toru Kikuchi Keisuke Nagasaki Yukie Iwata Makoto Uchiyama 《Clinical Pediatric Endocrinology》2004,13(1):55-58
This study aimed to investigate the levels of serum low-density lipoprotein
cholesterol (LDLC) using direct measurement in healthy Japanese school children. The
subjects were 621 children (325 boys and 296 girls) aged 9 to 10 in the 4th grade, and 688
children (334 boys and 354 girls) aged 12 to 13 in the 7th grade. The levels of serum LDLC
and high-density lipoprotein cholesterol were measured by direct determination (Cholestest
LDL and Cholestest NHDL; Daiichi Pure Chemicals Co., Ltd., Tokyo, Japan). In boys in the
4th grade, the mean, the 75th, the 90th and the 95th percentiles of LDLC levels (mg/dl)
were 91.6, 104, 124 and 134, respectively. In girls in the 4th grade, they were 92.8, 108,
122 and 130. In boys in the 7th grade, they were 83.4, 96, 113 and 123. In girls in the
7th grade, they were 93.0, 106, 126 and 137. Serum LDLC levels in boys in the 7th grade
were lower than those of other groups. The direct measurement of serum LDLC level is
useful for evaluation of dyslipidemia in healthy school children, because the method is
applicable to non-fasting serum. 相似文献
90.
目的 探讨恶性血液病患者血清红细胞生成素(Epo)的含量及其意义。方法 采用夹心酶联免疫法测定40例恶性血液病患者及18例健康人血清Epo,同时检测其血红蛋白及红细胞数。结果 恶性血液病中,急性白血病及多发性骨髓瘤的Epo较正常人明显增高(P<0.001),其血红蛋白值则明显低于正常人(P<0.001),慢性白血病及淋巴瘤的Epo也比正常人高(P分别为<0.002及<0.05),但其血红蛋白值则与正常人无显著差异(P>0.05)。各组病人血清Epo水平均与血红蛋白及红细胞数呈负相关。结论 恶性血液病血清Epo水平较对照组明显升高,并与血红蛋白及红细胞数呈负相关。除贫血、缺氧,导致体内Epo活性反馈,使患者Epo水平增高外,可能还和红系祖细胞利用Epo减少有关。rhEpo对Epo基础值不太高的某些恶性血液病伴发的贫血是一种有效的治疗措施。 相似文献